Home
/ Clario
/ Competitors

Clario Competitors and Similar CompaniesClear all

Clario's competitors and similar companies include Cytel, RTI International and Syneos Health.

	Clario Clario (also known as eResearchTechnology, formerly ERT) is a developer of clinical data collection solutions for use in clinical trials.	Cytel Cytel is a provider of data science and analytic solutions for drug development and commercialization.	RTI International RTI International (Research Triangle Institute) is a scientific research institute.	Syneos Health Syneos Health (formerly known as INC Research) is a biopharmaceutical solutions company.
Founding Date	Founding Date 1972	Founding Date 1987	Founding Date 1958	Founding Date 1998
Type	Type Private	Type Private	Type Private	Type Subsidiary
Tags	Tags Technology clinical research data collection enterprise software	Tags Healthcare biotech clinical research enterprise software	Tags Business Products & Services clinical research data collection market research safety	Tags Healthcare biotech clinical research pharma
Locations	Locations Philadelphia, US HQ Oudergem, BE Shanghai, CN San José, CR Estenfeld, DE Budapest, HU Bengaluru, IN see more	Locations Cambridge, US HQ Montréal, CA Toronto, CA Vancouver, CA Paris, FR Berlin, DE Wismar, DE see more	Locations Durham, US HQ San Salvador, SV Lyon, FR New Delhi, IN Jakarta, ID Nairobi, KE Barcelona, ES see more	Locations Morrisville, US HQ Buenos Aires, AR Adelaide, AU Montréal, CA Québec, CA Toronto, CA Beijing, CN see more
Employees	Employees 6,8711% increase	Employees 1,5961% increase	Employees 6,1002% decrease	Employees 29,000
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.4b (FY, 2024)	Revenue (est.) $5.4b (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $933.3m (FY, 2024)	Cost of goods $4.1b (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $433.1m (FY, 2024)	Gross profit $1.3b (FY, 2022)
Net income	Net income N/A	Net income N/A	Net income $34.8m (FY, 2024)	Net income $266.5m (FY, 2022)